-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Raises Price Target to $110

Benzinga·03/02/2026 12:43:46
Listen to the news
HC Wainwright & Co. analyst Arthur He maintains Vera Therapeutics (NASDAQ:VERA) with a Buy and raises the price target from $90 to $110.